Nadia Mensali

Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design

Nancy Gasper-Smith, Deanna M. Crossman, John F. Whitesides et al. · Journal of Virology · 2008 · 92 citations · Full text

Plasma Microparticles, Immunology, Pathology +19

NK cells specifically TCR-dressed to kill cancer cells

Nadia Mensali, Pierre Dillard, Michaël Hebeisen et al. · EBioMedicine · 2019 · 75 citations · Full text

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Espen B. Ellingsen, Elin Aamdal, Tormod Kyrre Guren et al. · Journal for ImmunoTherapy of Cancer · 2022 · 36 citations · Full text

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

Nadia Mensali, Hakan Köksal, Sandy Joaquina et al. · Nature Communications · 2023 · 36 citations · Full text

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity

Nadia Mensali, Amalie Grenov, Niladri Bhusan Pati et al. · OncoImmunology · 2019 · 31 citations · Full text